Zepbound vs Mounjaro: Are They the Same?
Zepbound vs Mounjaro: Are They the Same?

Introduction
If you’ve heard of Zepbound and Mounjaro, you might be wondering:
“Aren’t these the same drug?”
The short answer is: Yes, they contain the same active ingredient—but they are approved for different conditions and used in different ways.
This blog will explain the key similarities and differences between Zepbound and Mounjaro, including their FDA approvals, insurance implications, and how to choose the right one for your goals.
Quick Overview: Zepbound vs Mounjaro
Feature | Zepbound | Mounjaro |
Active Ingredient | Tirzepatide | Tirzepatide |
FDA Approved For | Obesity / Overweight | Type 2 Diabetes |
Weight Loss Use |
|
|
Insurance Coverage | Varies, often harder to get | Strong for diabetes |
Average Weight Loss | Up to 22.5% | ~15–20% (in diabetes patients) |
Dosing Schedule | Weekly injection | Weekly injection |
What Do They Have in Common?
Same active ingredient: Tirzepatide
Same delivery method: Once-weekly injection pen
Same mechanism of action:
- Mimics GLP-1 and GIP hormones
- Suppresses appetite
- Improves insulin sensitivity
- Slows gastric emptying
Both medications offer significant weight loss, especially when paired with diet and exercise.
Learn more: Zepbound for Weight Loss – How It Works
Key Differences Between Zepbound and Mounjaro
Category | Zepbound | Mounjaro |
Primary Use | Weight loss | Type 2 diabetes |
FDA Approval Date | November 2023 | May 2022 |
Insurance Coverage | Less likely (unless for obesity) | More likely (for diabetes) |
Prescription Coding | Weight management codes (ICD-10: E66) | Diabetes codes (ICD-10: E11) |
If you’re taking it for weight loss, Zepbound is the better insurance-aligned choice.
Dosing Comparison
Both medications follow the same titration schedule:
Week(s) | Dose |
Weeks 1–4 | 2.5 mg/week |
Weeks 5–8 | 5 mg/week |
Weeks 9–12 | 7.5 mg/week (optional) |
Weeks 13+ | 10–15 mg/week |
Your provider will choose the maintenance dose that works best based on tolerance and results.
Which One Is Covered by Insurance?
Scenario | Zepbound | Mounjaro |
You have Type 2 diabetes |
|
|
You are obese or overweight |
|
|
You’re using it for weight loss only |
|
|
See: How to Get Zepbound Covered by Insurance
When to Choose Zepbound
You meet the FDA criteria for obesity treatment (BMI ≥30 or ≥27 + comorbidity)
You want to avoid off-label use for weight loss
You’re applying for insurance coverage based on obesity, not diabetes
Your provider is focused on weight loss goals
When to Choose Mounjaro
You have Type 2 diabetes and need blood sugar management
Your insurance covers Mounjaro but not Zepbound
You were prescribed Mounjaro off-label for weight loss (and it’s working for you)
Some patients start on Mounjaro for coverage purposes and switch to Zepbound when appropriate.
Final Thoughts
Zepbound and Mounjaro are clinically identical in terms of their active ingredient and mechanism—but they’re used and billed differently. Choosing the right one depends on your diagnosis, insurance situation, and treatment goals.
Zepbound is the go-to for weight loss
Mounjaro is the go-to for Type 2 diabetes
Both are backed by strong clinical results and safe for long-term use
To compare these medications side-by-side and check your eligibility, visit our Tirzepatide Treatment Guide.